Healthcare Jul 06, 2021 09:13 AM (GMT+8) · EqualOcean
Yiou health learned on the 6th that Zhizhong Technology Co., Ltd. (hereinafter referred to as "Zhizhong technology"), a provider of medical device technology transformation services, has recently completed tens of millions of RMB a + round of financing, which is led by Zhejiang venture capital, followed by Xiaoshan science and Technology City Industrial Development Fund and Wuhan Biotechnology Research Institute Baiying fund. Zhizhong technology, founded in 2011, is a medical device technology transformation service platform, focusing on providing medical device enterprises with integrated solutions such as clinical trials, regulatory consultation, inspection and testing, entrusted R & D, consultation and training. So far, Zhizhong technology has gained the trust and recognition of more than 1000 medical device manufacturers and partners. In addition, Zhizhong technology established the medical device inspection and Research Institute in Wuhan in 2018 and obtained the CMA qualification. The inspection and research institute includes five laboratories, including electromagnetic compatibility, safety regulation, environmental test and reliability, packaging verification and microbiology. Zeng Jianhui, founder of Zhizhong technology, said: "the funds raised in this round will be mainly used in two aspects. One is to increase and deepen the investment and layout in the cro field, focus more on the application of new technologies in key customers and medical devices, improve the support level of Wuhan headquarters and the technical strength of the Institute, enhance their professional ability and customer brand loyalty, and realize strategic cooperation with customers The goal of common development; The second is to build Zhizhong national technology transformation center (CDO) and East China cro center in Xiaoshan, Hangzhou. "

This text is a result of machine translation.